USE OF NON-PEPTIDIC NK1 RECEPTOR ANTAGONISTS FOR THE PRODUCTION OF APOPTOSIS IN TUMOUR CELLS

• 收藏
• 分享

专利权人:

NK-1 IP LIMITED

发明人:

Miguel MUÑOZ SÁEZ

申请号：

US15850496

公开号：

US20180117027A1

申请日:

2017.12.21

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The invention relates to the use of substance P antagonists and, in particular, the use of non-peptidic NK1 receptor antagonists for the treatment of cancer and, more specifically, human melanoma, neuroblastoma, glioma, human Hodgkin's lymphoma KM-H2, lymphoblastic leukemia, human rhabdomyosarcoma, human breast carcinoma, human Burkitt's lymphoma, human lung carcinoma, human Ewing's sarcoma, human glioma and human osteosarcoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/